BetterLife Pharma Valuation
| BETRF Stock | USD 0.09 0.01 9.64% |
BetterLife Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of BetterLife Pharma from analyzing the firm fundamentals such as Return On Equity of -44.17, current valuation of 12.42 M, and Shares Owned By Insiders of 8.41 % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that BetterLife Pharma's price fluctuation is out of control at this time. Calculation of the real value of BetterLife Pharma is based on 3 months time horizon. Increasing BetterLife Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BetterLife otc stock is determined by what a typical buyer is willing to pay for full or partial control of BetterLife Pharma. Since BetterLife Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BetterLife OTC Stock. However, BetterLife Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.091 | Real 0.0754 | Hype 0.09 | Naive 0.0894 |
The real value of BetterLife OTC Stock, also known as its intrinsic value, is the underlying worth of BetterLife Pharma OTC Stock, which is reflected in its stock price. It is based on BetterLife Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BetterLife Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BetterLife Pharma helps investors to forecast how BetterLife otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BetterLife Pharma more accurately as focusing exclusively on BetterLife Pharma's fundamentals will not take into account other important factors: BetterLife Pharma Total Value Analysis
BetterLife Pharma is currently projected to have takeover price of 12.42 M with market capitalization of 9.49 M, debt of 34.56 K, and cash on hands of 14.41 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BetterLife Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.42 M | 9.49 M | 34.56 K | 14.41 K |
BetterLife Pharma Asset Utilization
One of the ways to look at asset utilization of BetterLife is to check how much profit was generated for every dollar of assets it reports. BetterLife Pharma shows a negative utilization of assets of -4.05 percent, losing $0.0405 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of BetterLife Pharma shows how discouraging it operates for each dollar spent on its assets.BetterLife Pharma Ownership Allocation
BetterLife Pharma holds a total of 90.1 Million outstanding shares. BetterLife Pharma shows 8.41 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BetterLife Pharma Profitability Analysis
Net Loss for the year was (12.16 M) with loss before overhead, payroll, taxes, and interest of (22.81 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BetterLife Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BetterLife Pharma and how it compares across the competition.
About BetterLife Pharma Valuation
The otc valuation mechanism determines BetterLife Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of BetterLife Pharma. We calculate exposure to BetterLife Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BetterLife Pharma's related companies.BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada. Betterlife Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct BetterLife Pharma's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates BetterLife Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BetterLife Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BetterLife Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BetterLife Pharma's revenue streams: Identify BetterLife Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BetterLife Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BetterLife Pharma's growth potential: Evaluate BetterLife Pharma's management, business model, and growth potential.
- Determine BetterLife Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BetterLife Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
BetterLife Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as BetterLife Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 85.2 M | |
| Retained Earnings | -103.2 M |
Complementary Tools for BetterLife OTC Stock analysis
When running BetterLife Pharma's price analysis, check to measure BetterLife Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BetterLife Pharma is operating at the current time. Most of BetterLife Pharma's value examination focuses on studying past and present price action to predict the probability of BetterLife Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BetterLife Pharma's price. Additionally, you may evaluate how the addition of BetterLife Pharma to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |